Sexual Function in Patients Suspected of Non-muscle Invasive Bladder Cancer

Herlev Hospital

Status: Completed

Conditions: Hematuria; Erectile Dysfunction; Urinary Bladder Neoplasms; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological

Treatments: Other: EORTC QLQ-C30 and EORTC BLS-24 questionnaire

Study type: Observational

Funder types: Other

Identifiers

NCT02381912

SSBC-2015

Details and patient eligibility

About

The purpose of the study is to investigate sexual function in patients suspected of non muscle invasive bladder cancer (NMIBC). The investigators hypothesis is that reduced sexual function is underdiagnosed in patients with non-muscle invasive bladder cancer and that active examination and treatment may worsen the sexual function.

Enrollment: 210 patients

Sex: All

Ages: 40+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with primary hematuria, both gross and microscopic
• Men and women older or equal to 40 years of age
• Signed informed consent statement

Exclusion criteria

• Men and women younger than 40 years of age
• Patients with recurrent hematuria and known causative disease
• Already known urogenital cancer
• Previous massive pelvic surgery or pelvic radiotherapy
• TUR-P within the last 2 months
• Participants diagnosed with tumors originating from the ureters, renal pelvis and kidney, and bladder tumors at T stage more than or equal to T1b.

Trial design

210 participants in 2 patient groups

Hematuria - NMIBC

Description:

Primary hematuria due to NMIBC.

Treatment:

Other: EORTC QLQ-C30 and EORTC BLS-24 questionnaire

Hematuria - other cause

Description:

Other non-malignant cause of hematuria.

Treatment:

Other: EORTC QLQ-C30 and EORTC BLS-24 questionnaire